ST Segment Elevation Myocardial Infarction (STEMI)

DBCOND0061688Cardiovascular Diseases Signs, Symptoms, and General Pathologies

ST Segment Elevation Myocardial Infarction (STEMI) is the indication for 4 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as: STEMI · ST Elevation Myocardial Infarction · ST Elevation Myocardial Infarction (STEMI) · ST Segment Elevation Myocardial Infarction · ST Elevated Myocardial Infarction
Classified under: Cardiovascular Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Bivalirudin
Clopidogrel
Fondaparinux
Heparin

Resolves to

Vocabularies

MeSHM000617719ICD-10I21SNOMED CT194811003MedDRA10000891UMLSC0155626

What you can answer from here — as of November 01, 2026

4Indicated drugsWith each drug's targets and mechanism

Listed above

4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

319Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for ST Segment Elevation Myocardial Infarction (STEMI) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account